XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -33.67%150M | -33.67%150M | -22.76%149.16M | -69.56%106.68M | -69.72%122.84M | -23.78%226.15M | -23.78%226.15M | 96.64%193.11M | 349.28%350.49M | 94.08%405.72M |
-Cash and cash equivalents | -33.67%150M | -33.67%150M | -22.76%149.16M | -69.56%106.68M | -69.72%122.84M | -23.78%226.15M | -23.78%226.15M | 96.64%193.11M | 349.28%350.49M | 94.08%405.72M |
Receivables | -33.98%50.32M | -33.98%50.32M | 26.23%103.73M | 21.97%106.75M | 19.06%94.39M | -2.60%76.21M | -2.60%76.21M | 26.48%82.17M | 9.25%87.52M | 26.76%79.29M |
-Accounts receivable | -33.98%50.32M | -33.98%50.32M | 35.52%73.02M | 30.45%78.26M | 25.02%66M | 44.35%76.21M | 44.35%76.21M | 28.42%53.88M | 2.11%59.99M | 14.66%52.79M |
-Loans receivable | ---- | ---- | 8.54%30.71M | 3.50%28.49M | 7.17%28.4M | ---- | ---- | 22.96%28.29M | 28.92%27.53M | 60.51%26.5M |
Inventory | 14.51%3.45B | 14.51%3.45B | 17.09%3.58B | 15.37%3.3B | 13.35%3.11B | 6.57%3.02B | 6.57%3.02B | -1.59%3.06B | -4.86%2.86B | 2.28%2.74B |
Prepaid assets | -20.61%37.95M | -20.61%37.95M | -15.61%47.52M | 4.08%39.39M | 9.11%45.56M | 7.78%47.79M | 7.78%47.79M | 11.82%56.31M | -13.43%37.85M | -12.23%41.76M |
Restricted cash | -75.93%28.33M | -75.93%28.33M | 44.68%100.51M | 58.42%66.61M | 285.09%106.2M | 72.23%117.7M | 72.23%117.7M | -26.91%69.47M | -58.89%42.05M | -49.24%27.58M |
Total current assets | 5.93%3.96B | 5.93%3.96B | 17.04%4.24B | 8.41%3.87B | 7.03%3.69B | 6.09%3.74B | 6.09%3.74B | 0.32%3.62B | 1.34%3.57B | 6.11%3.45B |
Non current assets | ||||||||||
Net PPE | 33.71%274.62M | 33.71%274.62M | 103.66%312.11M | 95.50%255.46M | 120.54%234.86M | 132.58%205.38M | 132.58%205.38M | 233.22%153.25M | 205.64%130.67M | 138.29%106.49M |
-Gross PPE | 32.87%306.85M | 32.87%306.85M | 103.66%312.11M | 95.50%255.46M | 120.54%234.86M | 121.40%230.94M | 121.40%230.94M | 233.22%153.25M | 205.64%130.67M | 138.29%106.49M |
-Accumulated depreciation | -26.10%-32.24M | -26.10%-32.24M | ---- | ---- | ---- | -59.70%-25.57M | -59.70%-25.57M | ---- | ---- | ---- |
Goodwill and other intangible assets | 36.18%83.51M | 36.18%83.51M | 21.46%73.96M | 16.00%66.15M | 19.38%64.82M | 12.40%61.33M | 12.40%61.33M | 100.32%60.89M | 87.62%57.03M | 78.63%54.3M |
-Goodwill | 35.25%41.11M | 35.25%41.11M | 29.74%39.43M | 5.55%32.08M | 5.55%32.08M | 0.00%30.4M | 0.00%30.4M | 0.00%30.4M | 0.00%30.4M | 0.00%30.4M |
-Other intangible assets | 37.09%42.4M | 37.09%42.4M | 13.22%34.52M | 27.93%34.07M | 36.96%32.73M | 28.01%30.93M | 28.01%30.93M | --30.49M | --26.63M | --23.9M |
Investments and advances | 14.32%31.86M | 14.32%31.86M | ---- | ---- | ---- | --27.87M | --27.87M | ---- | ---- | ---- |
Financial assets | 80.06%92.49M | 80.06%92.49M | 87.97%98.14M | 101.22%90.6M | 49.42%67.91M | 2.10%51.37M | 2.10%51.37M | -42.50%52.21M | -52.22%45.02M | -52.01%45.45M |
Non current deferred assets | 30.72%22.22M | 30.72%22.22M | -8.19%17.24M | -14.70%17.43M | -15.94%17.6M | -18.50%17M | -18.50%17M | -50.74%18.78M | -16.26%20.43M | -21.53%20.94M |
Other non current assets | 74.45%69.92M | 74.45%69.92M | -4.34%40.32M | -5.59%31.73M | -5.71%32.57M | -86.10%40.08M | -86.10%40.08M | -34.48%42.14M | -42.20%33.61M | -25.49%34.54M |
Total non current assets | 42.58%574.62M | 42.58%574.62M | 65.54%541.77M | 60.89%461.37M | 59.62%417.75M | -19.79%403.01M | -19.79%403.01M | 21.38%327.27M | 14.74%286.76M | 7.78%261.72M |
Total assets | 9.50%4.53B | 9.50%4.53B | 21.06%4.78B | 12.31%4.33B | 10.74%4.11B | 9.69%4.14B | 9.69%4.14B | 1.79%3.95B | 2.22%3.86B | 6.22%3.71B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -9.63%133.09M | -9.63%133.09M | 2.68%165.37M | 8.34%158.78M | 34.56%144.25M | 37.73%147.27M | 37.73%147.27M | 71.24%161.05M | 24.85%146.56M | -22.07%107.2M |
-accounts payable | -9.63%133.09M | -9.63%133.09M | 2.68%165.37M | 8.34%158.78M | 27.47%135.78M | 37.73%147.27M | 37.73%147.27M | 71.24%161.05M | 24.85%146.56M | 16.40%106.53M |
-Total tax payable | --0 | --0 | --0 | --0 | 1,150.22%8.46M | --0 | --0 | ---- | ---- | -98.53%677K |
Current accrued expenses | -7.97%165.78M | -7.97%165.78M | -5.18%163.25M | -1.49%163.74M | 2.95%179.94M | 6.21%180.14M | 6.21%180.14M | -2.24%172.17M | -15.53%166.21M | -4.92%174.78M |
Current debt and capital lease obligation | --135.5M | --135.5M | --414M | --111M | ---- | ---- | ---- | ---- | ---- | ---- |
-Current debt | --135.5M | --135.5M | --414M | --111M | ---- | ---- | ---- | ---- | ---- | ---- |
Current liabilities | 32.67%434.37M | 32.67%434.37M | 122.86%742.62M | 38.61%433.52M | 14.97%324.19M | 18.40%327.41M | 18.40%327.41M | -23.43%333.22M | -31.28%312.77M | -12.26%281.98M |
Non current liabilities | ||||||||||
Long term provisions | 29.98%45.73M | 29.98%45.73M | 26.05%41.95M | 13.99%39.28M | 17.38%36.86M | 16.76%35.18M | 16.76%35.18M | 13.99%33.28M | 143.94%34.46M | 132.59%31.41M |
Long term debt and capital lease obligation | 2.99%1.34B | 2.99%1.34B | 12.59%1.37B | 8.38%1.32B | 8.99%1.28B | 6.96%1.3B | 6.96%1.3B | -1.17%1.21B | -1.04%1.22B | -3.70%1.18B |
-Long term debt | 2.99%1.34B | 2.99%1.34B | 12.59%1.37B | 8.38%1.32B | 8.99%1.28B | 6.96%1.3B | 6.96%1.3B | 0.15%1.21B | 0.26%1.22B | -2.29%1.18B |
Employee benefits | 2.35%82.02M | 2.35%82.02M | 5.46%64.36M | 6.83%50.02M | 1.66%33.66M | -0.35%80.13M | -0.35%80.13M | -15.31%61.03M | -23.93%46.82M | -24.18%33.11M |
Derivative product liabilities | ---- | ---- | --1.09M | --0 | -42.14%979K | ---- | ---- | --0 | --0 | --1.69M |
Other non current liabilities | 10.75%8.79M | 10.75%8.79M | 9.37%17.29M | -0.34%18.81M | -14.01%14.4M | -55.69%7.93M | -55.69%7.93M | -63.97%15.81M | -66.34%18.87M | -74.45%16.75M |
Total non current liabilities | 3.67%1.48B | 3.67%1.48B | 12.64%1.49B | 8.34%1.43B | 8.64%1.37B | 5.79%1.43B | 5.79%1.43B | -3.60%1.32B | -3.25%1.32B | -6.32%1.26B |
Total liabilities | 9.08%1.91B | 9.08%1.91B | 34.81%2.23B | 14.13%1.87B | 9.79%1.69B | 7.94%1.75B | 7.94%1.75B | -8.37%1.66B | -10.26%1.63B | -7.46%1.54B |
Shareholders'equity | ||||||||||
Share capital | -2.52%310K | -2.52%310K | -1.57%313K | -2.19%313K | -0.63%318K | 0.00%318K | 0.00%318K | 0.00%318K | -0.93%320K | -3.03%320K |
-common stock | -2.52%310K | -2.52%310K | -1.57%313K | -2.19%313K | -0.63%318K | 0.00%318K | 0.00%318K | 0.00%318K | -0.93%320K | -3.03%320K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 16.72%2.09B | 16.72%2.09B | 16.93%2B | 17.74%1.92B | 16.25%1.85B | 14.60%1.79B | 14.60%1.79B | 14.61%1.71B | 20.72%1.63B | 32.34%1.59B |
Paid-in capital | -11.14%526.96M | -11.14%526.96M | -5.94%547.72M | -7.89%540.57M | -1.88%569.58M | 1.40%592.99M | 1.40%592.99M | 0.45%582.33M | -1.65%586.86M | -7.48%580.49M |
Total stockholders'equity | 9.80%2.62B | 9.80%2.62B | 11.12%2.55B | 10.97%2.47B | 11.40%2.42B | 11.01%2.39B | 11.01%2.39B | 10.65%2.29B | 13.88%2.22B | 18.68%2.17B |
Total equity | 9.80%2.62B | 9.80%2.62B | 11.12%2.55B | 10.97%2.47B | 11.40%2.42B | 11.01%2.39B | 11.01%2.39B | 10.65%2.29B | 13.88%2.22B | 18.68%2.17B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |